OSTERWEIS CAPITAL MANAGEMENT INC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
OSTERWEIS CAPITAL MANAGEMENT INC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$3,663,000
-50.4%
55,140
-41.7%
0.20%
-47.4%
Q2 2021$7,385,000
+39.9%
94,660
+69.7%
0.38%
+31.9%
Q1 2021$5,277,000
-15.8%
55,790
+8.5%
0.29%
-23.0%
Q4 2020$6,268,000
+17.9%
51,440
-15.5%
0.37%
+4.2%
Q3 2020$5,317,000
+46.1%
60,860
+8.0%
0.36%
+36.0%
Q2 2020$3,640,00056,3500.26%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q1 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,750,000$260,122,0005.80%
Burrage Capital Management LLC 72,164$6,826,0005.53%
Consonance Capital Management LP 450,396$42,603,0004.54%
MPM BioImpact LLC 269,186$25,462,0003.20%
Orbimed Advisors 2,361,327$223,358,0002.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 81,541$7,711,0002.04%
SECTORAL ASSET MANAGEMENT INC 257,879$24,393,0001.85%
Nicholas Investment Partners, LP 218,847$20,701,0001.44%
Logos Global Management LP 140,000$13,243,0001.29%
SILVERARC CAPITAL MANAGEMENT, LLC 16,741$1,584,0000.86%
View complete list of TURNING POINT THERAPEUTICS I shareholders